CDT Equity (CDT) Payables (2021 - 2026)
CDT Equity's (CDT) quarterly Payables came in at $3.2 million in Q1 2026, down 5.57% YoY from $3.4 million in Q1 2025, and up 23.94% on a QoQ basis from $2.6 million in Q4 2025.
CDT Equity (CDT) Payables (2021 - 2026) Analysis & Trends
CDT Equity (CDT) has 6 years of Payables data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Payables fell 5.57% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 5.57% YoY) and the FY2025 annual result came in at $2.6 million, up 68.39% from the prior year.
- Payables improved to $3.2 million in Q1 2026, from $2.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $3.4 million in Q1 2025 to a low of $3875.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $1.1 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2023 — Payables surged 7641.94% — and 2026, when it slipped 5.57%.
- Tracing CDT's Payables over 5 years: stood at $175000.0 in 2022, then gained by 28.57% to $225000.0 in 2023, then soared by 579.11% to $1.5 million in 2024, then jumped by 68.39% to $2.6 million in 2025, then advanced by 23.94% to $3.2 million in 2026.
- The last three Payables figures came in at $3.2 million (Q1 2026), $2.6 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.86 Mn |
| Mar 31, 2026 | 3.19 Mn |
| Dec 31, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 3.38 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 225,000.00 |
| Sep 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 175,000.00 |
| Mar 31, 2022 | 3,875.00 |
| Dec 31, 2021 | 177,057.00 |